Navigation Links
Nile Therapeutics, Inc. Completes $3.4 Million Private Placement
Date:7/16/2009

SAN FRANCISCO, July 16 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced that it has completed a private placement of shares of its common stock and warrants to purchase additional common stock for aggregate gross proceeds of approximately $3.4 million. Riverbank Capital Inc., a FINRA member broker dealer acted as the exclusive placement agent for the transaction.

"We are extremely pleased to have the completed this financing," said Joshua Kazam, Chief Executive Officer, "which we believe will provide us with sufficient capital to complete our Phase 2 clinical study of CD-NP in acute heart failure patients with mild to moderate renal insufficiency."

The securities sold in the private placement have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration under such act and applicable state securities laws or an applicable exemption from those registration requirements. Nile has agreed to file a registration statement covering the resale of the shares issued in the private placement, including the shares issuable upon exercise of the warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas o
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oxygen Biotherapeutics, Inc. Announces Closing of Private Placement Financing Agreement
2. Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement
3. Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions
4. Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions
5. Prospect Therapeutics, Inc.s GCS-100 Inhibited Blood Vessel Formation in a Variety of Cancer Models
6. Cell Therapeutics, Inc. (CTI) to Present at 2009 BIO International Convention
7. Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
8. Cell Therapeutics, Inc. (CTI) to Report 2009 First Quarter Financial Results on May 7
9. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
10. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock
11. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... (PRWEB) September 11, 2014 DuPont ... excited to announce that it has appointed ... two wholly owned subsidiaries, Essex Grain Products ... of Zemea® USP propanediol in the food and ... following USA eastern and mid-western states: Alabama, ...
(Date:9/11/2014)... Calif. and LONDON ... and Cancer Research Technology (CRT), the charity,s development ... Inc. (OTCBB: ASTY), a biotechnology company in the ... Asterias, novel immunotherapy treatment AST-VAC2 into clinical trials ... AST-VAC2 represents the tenth treatment to enter ...
(Date:9/11/2014)... 11, 2014 The Stem Cell Institute, ... seminar about umbilical cord stem cell therapy on Saturday, September ... Hill Country Resort from 1:00 pm to 4:00 pm. ... PhD – “Umbilical Cord Stem Cell Clinical Trials for ... is the founder of the Stem Cell Institute and Medistem ...
(Date:9/10/2014)... September 11, 2014 Rutgers University’s ... Innovations in Dermatological Sciences conference Oct. 8 in ... how the university, industry and government sectors can ... use. , This conference is unique in bringing ... collaboration, to share their successes, best-practices, and lessons ...
Breaking Biology Technology:DuPont Tate & Lyle Bio Products Appoints Skidmore Sales as Distributor for Zemea® USP 2DuPont Tate & Lyle Bio Products Appoints Skidmore Sales as Distributor for Zemea® USP 3Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 2Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 3Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 4Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 5Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 6Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 7Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 8Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014 2Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014 3Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014 4Innovations in Dermatological Sciences 2014 2Innovations in Dermatological Sciences 2014 3
... Every surgical operation requires proper wound closure to ensure ... start-up business has received a $100,000 federal grant to ... Corp ., which develops tissue repair products and advanced ... Small Business Innovation Research grant. , ,The ...
... - With the U.S. economy showing alternating signs of ... to business organizations that might want to slow the ... a housing-induced recession. , ,The Information Technology and ... the Economic Benefits of the Information Technology Revolution, focused ...
... Evansville, Wis . - Gov. Jim Doyle may ... a 62,400-square-foot biodiesel plant that will be built here over ... made it possible. , ,The $60 million plant, to be ... fuel producer, will generate 45 million gallons of fuel per ...
Cached Biology Technology:Study affirms information technology-productivity link 2Study affirms information technology-productivity link 3Investors raise $25 million for biodiesel plant 2Investors raise $25 million for biodiesel plant 3
(Date:9/12/2014)... September 12, 2014 ... ) has announced the addition of the ... report to their offering. ,     (Logo: ... 2014 is a professional and in-depth study ... fingerprint lock industry. , ,The report provides ...
(Date:9/12/2014)... Research and Markets ( ... the  "Global Facial Recognition Market (2D Facial ... - Industry Analysis, Size, Share, Growth, Trends ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... was valued at USD 1.17 billion in ...
(Date:9/12/2014)... Sept. 12, 2014 Research and Markets ... IC Card Management System Industry Report 2014" report ... Card Management System Industry Report 2014 is a professional ... global IC card management system. The report ... classifications, applications and industry chain structure. The IC card ...
Breaking Biology News(10 mins):Global Fingerprint Lock Industry Report 2014 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 3Global IC Card Management System Industry Report 2014 2
... Obesity rates in the United States increased from 14.5% of ... 2009-2010. It,s believed that one contributing factor to expanding waistlines ... the ability to control energy intake may be affected by ... rate may impair the relationship between the sensory signals and ...
... the rapid and non-invasive characteristics and may ... Chunhua Chen and colleagues from Peking University, ... normobaric oxygen before focal cerebral ischemia, neurological ... reduced; the expression of hypoxia-inducible factor-1α, Notch-1, ...
... triangle depicting how many servings of each food group you ... MyPlate - the circle showing what a healthy meal looks ... Department of Agriculture (USDA) to help American consumers put the ... prompts us to think about what,s on our plate, illustrating ...
Cached Biology News:Slower-paced meal reduces hunger but affects calorie consumption differently 2Slower-paced meal reduces hunger but affects calorie consumption differently 3Who is using MyPlate? 2
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Synaptotagmin, phosphoSer309...
... Immunogen: ... region encompassing the human, mouse, ... Accession Number: ... Assurance: Routinely evaluated by ...
Goat polyclonal to PPP2R5D Immunogen: Peptide with sequence KRAEEFLTASQEAL, from C Terminus of the protein sequence according to NP_006236...
Biology Products: